Siflon Drugs Private Limited

Siflon Drugs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2010PTC067606 Incorporated 19 March 2010 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹6.38 Cr
▲ 9% YoY
Net loss · FY 2025
₹17.42 Lakh
Net margin -2.7%
EBITDA · FY 2025
₹43.64 Lakh
EBITDA margin 6.8%
Authorised capital
₹6.15 Cr
Registered with MCA
Paid-up capital
₹6.15 Cr
Issued & subscribed
Open charges
₹33.61 Cr
Satisfied ₹4.96 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
15
Provident fund records

About Siflon Drugs Private Limited

Data last updated:

Siflon Drugs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 19 March 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC067606. Its GSTIN is 36AAOCS4785P1Z8 (Telangana). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹6.15 Cr and a paid-up capital of ₹6.15 Cr. It is led by directors including Ananthaiah Rallapalli (Managing Director) and Parvathi Rallapalli.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.76 & 77 Manu Residency Mathri Nagar Miyapur, Hyderabad, Telangana, India – 500050.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.38 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹17.42 Lakh (net margin -2.7%) and EBITDA of ₹43.64 Lakh (EBITDA margin 6.8%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years.

The company has about 15 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹33.61 Cr and satisfied charges of ₹4.96 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it.

Siflon Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0007492). The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website siflondrugs.com.

Company details

CIN U24232TG2010PTC067606
Registration Number 067606
Incorporation Date 19 March 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Non-Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-09-0007492

CIN history

Siflon Drugs has one previous CIN (Corporate Identification Number): U24232AP2010PTC067606. The current CIN is U24232TG2010PTC067606, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2010PTC067606Current
U24232AP2010PTC067606Previous

Recognitions & Rankings of Siflon Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2022-23)
Udyam number
UDYAM-TS-09-0007492

Contact details

Siflon Drugs Private Limited's registered office is in Hyderabad, Telangana. Its website is siflondrugs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No.76 & 77 Manu Residency Mathri Nagar Miyapur, Hyderabad, Telangana, India – 500050
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare

To see the full contact details of Siflon Drugs Private Limited, buy the company report.

Comprehensive company report
Siflon Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Siflon Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Siflon Drugs Private Limited, buy the company report.

Financials of Siflon Drugs Private Limited

FY 2024 filings available

Siflon Drugs Private Limited reported revenue of ₹6.38 Cr (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹6.38 Cr ▲ 9%
Net loss · FY 2025
₹17.42 Lakh margin -2.7%
EBITDA · FY 2025
₹43.64 Lakh margin 6.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 38%
3 years · compounded
▲ 23%
5 years · compounded
▲ 26%

Revenue rose 9% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹43.64 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹17.42 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.8%
Net Profit Margin-2.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Siflon Drugs Private Limited, buy the company report.

Board of directors of Siflon Drugs Private Limited

Siflon Drugs has 3 directors on record. No former directors are listed.

Current Directors

Auditor

Siflon Drugs Private Limited is audited by Dinesh Kakarla & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Dinesh Kakarla & AssociatesFY 20230016508S

Shareholding

The shareholding of Siflon Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Siflon Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹33.61 Cr
Satisfied charges
₹4.96 Cr
Breakdown by lending institutions
Axis Bank Limited₹33.61 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Mar 2019100254464Axis Bank Limited₹6.83 CrOpen
30 Jul 201510588447Axis Bank Limited₹25 CrOpen
30 Jul 201510588407Axis Bank Limited₹1.78 CrOpen
09 May 201110294288Oriental Bank of Commerce₹4.96 CrSatisfied

To see the full charge records of Siflon Drugs Private Limited, buy the company report.

Total charge records: 4 View all charges

Credit ratings & regulatory alerts

Siflon Drugs Private Limited was last rated by Crisil on 27 Feb 2020.

Rating agencyRated onRating
Crisil27 Feb 2020

To see the full credit ratings and regulatory alerts of Siflon Drugs Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Siflon Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Siflon Drugs Private Limited has a workforce of 15 employees on its EPFO records as of Nov 2025, across 1 active EPFO establishment.

Employee count
15
Active EPFO establishments
1
Employee growth
-63.4%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2025-2615
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Siflon Drugs Private Limited, buy the company report.

GST

Siflon Drugs has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAOCS4785P1Z8TelanganaActive01 Jul 2017
37AAOCS4785P2Z5Andhra PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Siflon Drugs Private Limited, buy the company report.

Recent activity

Siflon Drugs Private Limited has 3 board changes on record since 2010: 3 appointments. The latest: Ananthaiah Rallapalli was appointed as Managing Director on 19 Mar 2010.

Charges
A charge with Axis Bank Limited of Rs. 6.83 Cr registered on 22 Mar 2019 with Charge ID 100254464 was modified on 27 Jan 2025.
AGM
Siflon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Siflon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited of Rs. 1.78 Cr registered on 30 Jul 2015 with Charge ID 10588407 was modified on 29 Jul 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 6.83 Cr with Charge ID 100254464 was registered on 22 Mar 2019.
Charges
A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 30 Jul 2015 with Charge ID 10588447 was modified on 08 Mar 2018.
Charges
A charge registered on 09 May 2011 via Charge ID 10294288 with Oriental Bank Of Commerce was fully satisfied on 21 Aug 2015.
Charges
A charge with Axis Bank Limited amounted to Rs. 25.00 Cr with Charge ID 10588447 was registered on 30 Jul 2015.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.78 Cr with Charge ID 10588407 was registered on 30 Jul 2015.
Charges
A charge with Oriental Bank Of Commerce amounted to Rs. 4.96 Cr with Charge ID 10294288 was registered on 09 May 2011.
Appointed
Ananthaiah Rallapalli was appointed as Managing Director.
Appointed
Parvathi Rallapalli was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Siflon Drugs is an active private limited company based in Hyderabad, Telangana, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 19 March 2010 (16+ years old) and is registered under CIN U24232TG2010PTC067606.

Siflon Drugs has 3 current directors:

The latest financial statements of Siflon Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Siflon Drugs is 36AAOCS4785P1Z8, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AAOCS4785P2Z5 (Andhra Pradesh).

The CIN (Corporate Identification Number) of Siflon Drugs is U24232TG2010PTC067606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Siflon Drugs has 4 court cases on record: 2 filed by the company and 2 filed against it. Most are in the district courts.

Siflon Drugs was incorporated on 19 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.

Ananthaiah Rallapalli was appointed as Managing Director on 19 Mar 2010. Parvathi Rallapalli was appointed as Director on 19 Mar 2010. Swetha Rallapalli was appointed as Director on 19 Mar 2010.

Yes, Siflon Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-TS-09-0007492).

Siflon Drugs can be reached through the website siflondrugs.com. Its registered office is in Hyderabad, Telangana, India.